Best Telehealth Clinics in Indiana (2026)

Indiana's telehealth statute is IC § 25-1-9.5 ("Telehealth Services and Prescriptions"). The law does not require a mandatory in-person visit before prescribing controlled substances via telehealth. Under IC § 25-1-9.5-8(b), a prescriber may issue a controlled substance prescription to a telehealth patient if they hold a valid controlled substance registration, meet federal DEA conditions, the prescription serves a legitimate medical purpose, the communication uses an audiovisual real-time interactive system, and the prescriber complies with Indiana's INSPECT prescription monitoring program.

Audio-only telehealth is explicitly insufficient for controlled substance prescribing. Video capability is required. After a first-time telehealth prescription (where no ongoing relationship exists), the provider must notify the patient's primary care provider, subject to patient consent. This notification is not required after two consecutive telehealth encounters establishing an ongoing relationship.

SEA 3 made several COVID-era expansions permanent, including prohibiting Medicaid from restricting patient location and originating sites. SEA 251 (2022) enacted the IMLC in Indiana, codified at IC § 25-22.5-16, with IMLC going live on July 5, 2023. Out-of-state providers need a telehealth provider certification under IC § 25-1-9.5-9.

HB 1202 (2025) requires Indiana Medicaid to cover FDA-approved obesity treatments effective July 1, 2025, making Indiana one of the states expanding GLP-1 access through Medicaid.

Indiana has 6.8 million residents. Provider availability is good, supported by IMLC membership and a relatively permissive telehealth framework. Of the 64 providers tracked, roughly 55 serve Indiana.

All major TRT providers serve Indiana. Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, 45 states including IN), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available.

GLP-1 availability is unrestricted. All national providers serve Indiana. Indiana Medicaid now covers FDA-approved obesity treatments per HB 1202.

All HRT, hair loss, and ED providers serve the state. Midi Health accepts insurance. No known state-specific provider exclusions for Indiana.

TRT pricing matches national rates. DudeMeds: $77/mo ($1,124/year). TRT Nation: $99/mo ($1,446/year). PeterMD: $99/mo ($1,188/year). Maximus: $100/mo ($1,300/year). BraverX: $129/mo ($1,548/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Indiana Medicaid coverage for obesity treatments (effective July 2025 per HB 1202) means qualifying patients may not need to pay out of pocket. Verify PA requirements with Indiana Medicaid.

Indiana does not tax prescription medications. The state sales tax is 7% but Rx drugs are exempt. Indiana has a flat income tax rate of 3.05%.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

TRT (testosterone replacement therapy)

Indiana does not require an in-person visit for TRT prescribing via telehealth (IC § 25-1-9.5-8). Audiovisual consultation is required; audio-only is insufficient. INSPECT must be checked. Both compounded and FDA-approved testosterone are available.

GLP-1 weight loss

No state-specific GLP-1 restrictions. Federal FDA compounding rules apply. Indiana Medicaid covers obesity treatments per HB 1202 (effective July 2025).

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Indiana. No additional state restrictions apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Indiana. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Indiana. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Indiana. Audiovisual telehealth required for any controlled peptide prescriptions. Non-controlled peptides have fewer restrictions.